🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/02/2011 | 66,94 | 67,75 | 66,66 | 66,87 | +1,50% | 1,63% | 1.153.000 |
| 07/02/2011 | 66,15 | 66,65 | 65,62 | 65,88 | -0,11% | 1,56% | 687.900 |
| 04/02/2011 | 65,46 | 66,42 | 65,32 | 65,95 | +0,55% | 1,68% | 535.700 |
| 03/02/2011 | 66,77 | 66,80 | 64,50 | 65,59 | -2,02% | 3,44% | 1.457.900 |
| 02/02/2011 | 68,72 | 69,48 | 66,94 | 66,94 | -2,97% | 3,70% | 920.500 |
| 01/02/2011 | 67,99 | 69,15 | 67,52 | 68,99 | +1,49% | 2,40% | 496.800 |
| 31/01/2011 | 68,18 | 68,55 | 67,36 | 67,98 | +0,06% | 1,75% | 269.600 |
| 28/01/2011 | 68,40 | 68,94 | 67,85 | 67,94 | -0,47% | 1,59% | 801.200 |
| 27/01/2011 | 68,13 | 68,74 | 67,49 | 68,26 | +0,19% | 1,83% | 338.300 |
| 26/01/2011 | 67,12 | 68,23 | 66,78 | 68,13 | +1,55% | 2,16% | 386.800 |
| 25/01/2011 | 66,59 | 67,11 | 65,68 | 67,09 | +0,74% | 2,15% | 344.700 |
| 24/01/2011 | 66,43 | 67,58 | 66,00 | 66,60 | +0,41% | 2,38% | 543.700 |
| 21/01/2011 | 67,66 | 67,78 | 66,18 | 66,33 | -1,57% | 2,36% | 530.400 |
| 20/01/2011 | 68,60 | 68,82 | 67,13 | 67,39 | -1,63% | 2,46% | 596.500 |
| 19/01/2011 | 68,60 | 69,06 | 68,00 | 68,51 | -0,17% | 1,55% | 502.800 |
| 18/01/2011 | 67,27 | 68,67 | 66,98 | 68,63 | +1,92% | 2,51% | 604.500 |
| 14/01/2011 | 66,76 | 67,34 | 65,90 | 67,34 | +0,51% | 2,16% | 278.300 |
| 13/01/2011 | 67,20 | 67,43 | 66,15 | 67,00 | -0,30% | 1,90% | 307.300 |
| 12/01/2011 | 67,60 | 67,64 | 66,73 | 67,20 | -0,24% | 1,35% | 258.000 |
| 11/01/2011 | 67,10 | 67,85 | 67,00 | 67,36 | +0,33% | 1,27% | 258.000 |
| 10/01/2011 | 66,56 | 67,55 | 66,46 | 67,14 | +0,21% | 1,64% | 520.500 |
| 07/01/2011 | 66,22 | 67,04 | 65,80 | 67,00 | +1,12% | 1,87% | 470.600 |
| 06/01/2011 | 66,34 | 66,43 | 65,78 | 66,26 | -0,45% | 0,98% | 353.400 |
| 05/01/2011 | 65,46 | 67,13 | 65,44 | 66,56 | +1,96% | 2,58% | 912.700 |
| 04/01/2011 | 64,80 | 65,64 | 63,60 | 65,28 | +1,43% | 3,15% | 832.100 |
| 03/01/2011 | 63,65 | 65,17 | 63,38 | 64,36 | +1,80% | 2,81% | 544.400 |
| 31/12/2010 | 63,17 | 63,94 | 62,60 | 63,22 | -0,17% | 2,12% | 401.900 |
| 30/12/2010 | 63,31 | 64,03 | 63,19 | 63,33 | -0,16% | 1,33% | 242.100 |
| 29/12/2010 | 63,59 | 63,66 | 63,11 | 63,43 | +0,05% | 0,86% | 169.800 |
| 28/12/2010 | 63,80 | 64,30 | 63,15 | 63,40 | -0,72% | 1,80% | 242.800 |